Published in J Vis Exp on February 16, 2011
Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med (2011) 1.94
Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy. Int J Clin Exp Pathol (2015) 0.84
Rapid and Efficient Production of Coronary Artery Ligation and Myocardial Infarction in Mice Using Surgical Clips. PLoS One (2015) 0.79
Antiapoptotic effect of simvastatin ameliorates myocardial ischemia/reperfusion injury. ISRN Pharmacol (2013) 0.79
Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair. Stem Cells Transl Med (2016) 0.77
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovasc Drugs Ther (2011) 0.76
Mesp1 Marked Cardiac Progenitor Cells Repair Infarcted Mouse Hearts. Sci Rep (2016) 0.75
Effects of β-adrenoceptor subtypes on cardiac function in myocardial infarction rats exposed to fine particulate matter (PM 2.5). Biomed Res Int (2014) 0.75
Universal definition of myocardial infarction. Circulation (2007) 11.69
Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics (2004) 2.97
Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem (2004) 2.24
Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation (2005) 1.42
Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem (2008) 1.29
Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Physiol Genomics (2002) 1.27
Rat infarct model of myocardial infarction and heart failure. J Card Fail (1995) 1.06
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest (2002) 2.26
Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation (2006) 2.00
Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther (2006) 1.58
The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther (2007) 1.56
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest (2003) 1.33
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol (2005) 1.23
Reduced cross-bridge dependent stiffness of skinned myocardium from mice lacking cardiac myosin binding protein-C. Mol Cell Biochem (2004) 1.07
Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radic Biol Med (2009) 1.06
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol (2007) 1.00
Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat (2006) 0.99
An unusual complication after aortic valve replacement. J Clin Ultrasound (2006) 0.93
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol (2007) 0.92
Length-dependent conductance of molecular wires and contact resistance in metal-molecule-metal junctions. Chemphyschem (2008) 0.91
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol (2006) 0.87
Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP). J Mol Biol (2013) 0.83
Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. Am J Physiol Heart Circ Physiol (2003) 0.82
Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium. Hypertension (2003) 0.81
Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascade. PLoS One (2013) 0.81
Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. Prostaglandins Other Lipid Mediat (2007) 0.81
Growth of compound Bi(III)- VI(A)-VII(A) crystals with special morphologies under mild conditions. Inorg Chem (2002) 0.80
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction. Eur J Clin Pharmacol (2014) 0.80
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. Am J Physiol Heart Circ Physiol (2007) 0.79
Ab initio investigations of the electric field dependence of the geometric and electronic structures of molecular wires. J Phys Chem A (2006) 0.79
Effect of backbone flexibility on charge transfer rates in peptide nucleic acid duplexes. J Am Chem Soc (2012) 0.79
Alveolar bone turnover and periodontal ligament width are controlled by Wnt. J Periodontol (2014) 0.79
Characterization of the prostaglandin H2 mimic: binding to the purified human thromboxane A2 receptor in solution. Arch Biochem Biophys (2008) 0.79
Theoretical investigation into molecular diodes integrated in series using the non-equilibrium Green's function method. Phys Chem Chem Phys (2010) 0.78
The effect of teeth extraction for orthodontic treatment on the upper airway: a systematic review. Sleep Breath (2015) 0.78
The effect of oxygen heteroatoms on the single molecule conductance of saturated chains. J Phys Chem B (2012) 0.77
From restoration to regeneration: periodontal aging and opportunities for therapeutic intervention. Periodontol 2000 (2016) 0.76
Theoretical investigations on the geometric and electronic structures of phenylene-acetylene macrocycles. Chemphyschem (2006) 0.76
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovasc Drugs Ther (2011) 0.76
Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling. Peptides (2011) 0.76
Mechanisms of angiotensin II-mediated decreases in intraneuronal Ca2+ in calcium-loaded stellate ganglion neurons. Hypertension (2005) 0.75
Cardiac syndrome X. N Engl J Med (2002) 0.75
Mechanisms of angiotensin II-induced ERK1/2 activation in fetal cardiomyocytes. Horm Mol Biol Clin Investig (2010) 0.75
Floc destruction and its impact on dewatering properties in the process of using flat-sheet membrane for simultaneous thickening and digestion of waste activated sludge. Bioresour Technol (2008) 0.75
A scanning tunneling microscope break junction method with continuous bias modulation. Nanoscale (2015) 0.75
Conformational analysis of diphenylacetylene under the influence of an external electric field. Phys Chem Chem Phys (2007) 0.75
Theoretical analysis of the potential distribution and transportation behavior of the ordered alkyl monolayer-silicon junction. Phys Chem Chem Phys (2006) 0.75
Study of the photodegradation kinetics and pathways of hexaflumuron in liquid media. Photochem Photobiol (2014) 0.75
Theoretical investigation on molecular rectification on the basis of asymmetric substitution and proton transfer reaction. J Chem Phys (2008) 0.75
Where, and how, does a nanowire break? Nano Lett (2007) 0.75